Justin C. Wheat

Dr. Justin C. Wheat

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LCLuis A. Carvajal
Luis A. Carvajal
DNDaniela Ben Neriah
Daniela Ben Neriah
ASAdrien Senecal
Adrien Senecal
LBLumie Benard
Lumie Benard
VTVictor Thiruthuvanathan
Victor Thiruthuvanathan
USUlrich Steidl
Ulrich Steidl
Dual inhibition of MDMX and MDM2 by an α-helical p53-stapled peptide (ALRN-6924) results in robust antitumor activity in acute myeloid leukemia.

8 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SHSean E. Healton
Sean E. Healton
HPHugo D. Pinto
Hugo D. Pinto
LMLaxmi N. Mishra
Laxmi N. Mishra
GHGregory A. Hamilton
Gregory A. Hamilton
JWJustin C. Wheat
Justin C. Wheat
ASArthur I. Skoultchi
Arthur I. Skoultchi
Significance: Eukaryotic genomes harbor a vast number of “selfish” DNA elements, including transposable elements and repetitive sequences. They constitute nearly 50% of the human genome and need to be silenced to maintain the integrity of the genome. Aberrant expression of such sequences, possibly due to failure of silencing mechanisms, is associated with human diseases, including cancer. Silencing of these “selfish” DNAs involves methylation of specific lysine residues in the nucleosome core particles that help package these DNA elements into chromatin in the cell nucleus. Here we demonstrate that H1 linker histones, the most abundant chromatin-binding proteins, are critical for silencing of these sequences, by promoting repressive lysine methylation and further compacting these elements into more condensed chromatin structures.

22 August 2016 in Frontiers in Oncology
Verified
Journal Article
Open access
HSHanae Sato
Hanae Sato
JWJustin C. Wheat
Justin C. Wheat
USUlrich Steidl
Ulrich Steidl
KIKeisuke Ito
Keisuke Ito
In recent years, advances in next-generation sequencing (NGS) technology have provided the opportunity to detect putative genetic drivers of disease, particularly cancers, with very high sensitivity. This knowledge has substantially improved our understanding of tumor pathogenesis. In hematological malignancies such as acute myeloid leukemia and myelodysplastic syndromes, pioneering work combining multi-parameter flow cytometry and targeted resequencing in leukemia have clearly shown that different classes of mutations appear to be acquired in particular sequences along the hematopoietic differentiation hierarchy. Moreover, as these mutations can be found in “normal” cells recovered during remission and can be detected at relapse, there is strong evidence for the existence of “pre-leukemic” stem cells (pre-LSC). These cells, while phenotypically normal by flow cytometry, morphology, and functional studies, are speculated to be molecularly poised to transform owing to a limited number of predisposing mutations. Identifying these “pre-leukemic” mutations and how they propagate a pre-malignant state has important implications for understanding the etiology of these disorders and for the development of novel therapeutics. NGS studies have found a substantial enrichment for mutations in epigenetic/chromatin remodeling regulators in pre-LSC, and elegant genetic models have confirmed that these mutations can predispose to a variety of hematological malignancies. In this review, we will discuss the current understanding of pre-leukemic biology in myeloid malignancies and how mutations in two key epigenetic regulators, DNMT3A and TET2, may contribute to disease pathogenesis.

25 July 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SXShaojun Xing
Shaojun Xing
PSPeng Shao
Peng Shao
FLFengyin Li
Fengyin Li
XZXudong Zhao
Xudong Zhao
WSWooseok Seo
Wooseok Seo
HXHai-Hui Xue
Hai-Hui Xue
Tle/Groucho proteins are transcriptional corepressors interacting with Tcf/Lef and Runx transcription factors, but their physiological roles in T cell development remain unknown. Conditional targeting of Tle1, Tle3 and Tle4 revealed gene dose–dependent requirements for Tle proteins in CD8+ lineage cells. Upon ablating all three Tle proteins, generation of CD8+ T cells was greatly diminished, largely owing to redirection of MHC-I–selected thymocytes to CD4+ lineage; the remaining CD8-positive T cells showed aberrant up-regulation of CD4+ lineage-associated genes including Cd4, Thpok, St8sia6, and Foxp3. Mechanistically, Tle3 bound to Runx-occupied Thpok silencer, in post-selection double-positive thymocytes to prevent excessive ThPOK induction and in mature CD8+ T cells to silence Thpok expression. Tle3 also bound to Tcf1-occupied sites in a few CD4+ lineage-associated genes, including Cd4 silencer and St8sia6 introns, to repress their expression in mature CD8+ T cells. These findings indicate that Tle corepressors are differentially partitioned to Runx and Tcf/Lef complexes to instruct CD8+ lineage choice and cooperatively establish CD8+ T cell identity, respectively.

13 June 2013 in Blood
Verified
Journal Article
Closed access
PDF file
YZYiyun Zhang
Yiyun Zhang
JWJianfeng Wang
Jianfeng Wang
JWJustin C. Wheat
Justin C. Wheat
XCXi Chen
Xi Chen
SJShan Jin
Shan Jin
JYJing-Ruey Joanna Yeh
Jing-Ruey Joanna Yeh
Developing novel therapies that suppress self-renewal of leukemia stem cells may reduce the likelihood of relapses and extend long-term survival of patients with acute myelogenous leukemia (AML). AML1-ETO (AE) is an oncogene that plays an important role in inducing self-renewal of hematopoietic stem/progenitor cells (HSPCs), leading to the development of leukemia stem cells. Previously, using a zebrafish model of AE and a whole-organism chemical suppressor screen, we have discovered that AE induces specific hematopoietic phenotypes in embryonic zebrafish through a cyclooxygenase (COX)-2 and β-catenin–dependent pathway. Here, we show that AE also induces expression of the Cox-2 gene and activates β-catenin in mouse bone marrow cells. Inhibition of COX suppresses β-catenin activation and serial replating of AE+ mouse HSPCs. Genetic knockdown of β-catenin also abrogates the clonogenic growth of AE+ mouse HSPCs and human leukemia cells. In addition, treatment with nimesulide, a COX-2 selective inhibitor, dramatically suppresses xenograft tumor formation and inhibits in vivo progression of human leukemia cells. In summary, our data indicate an important role of a COX/β-catenin–dependent signaling pathway in tumor initiation, growth, and self-renewal, and in providing the rationale for testing potential benefits from common COX inhibitors as a part of AML treatments. Key Points AE induces hematopoietic self-renewal through a COX/prostaglandin E2/β-catenin signaling pathway. Clinically available COX inhibitors may target AML stem cells and suppress AML of various karyotypes.

25 August 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JWJustin C. Wheat
Justin C. Wheat
DKDaniela S. Krause
Daniela S. Krause
TSThomas H. Shin
Thomas H. Shin
XCXi Chen
Xi Chen
JWJianfeng Wang
Jianfeng Wang
DSDavid A. Sweetser
David A. Sweetser
Hematopoiesis is a complex process that relies on various cell types, signaling pathways, transcription factors and a specific niche. The integration of these various components is of critical importance to normal blood development, as deregulation of these may lead to bone marrow failure or malignancy. Tle4, a transcriptional corepressor, acts as a tumor suppressor gene in a subset of acute myeloid leukemia, yet little is known about its function in normal and malignant hematopoiesis or in mammalian development. We report here that Tle4 knockout mice are runted and die at around four weeks with defects in bone development and BM aplasia. By two weeks of age, Tle4 knockout mice exhibit leukocytopenia, B cell lymphopenia, and significant reductions in hematopoietic stem and progenitor cells. Tle4 deficient hematopoietic stem cells are intrinsically defective in B lymphopoiesis and exhaust upon stress, such as serial transplantation. In the absence of Tle4 there is a profound decrease in bone mineralization. In addition, Tle4 knockout stromal cells are defective at maintaining wild-type hematopoietic stem cell function in vitro. In summary, we illustrate a novel and essential role for Tle4 in the extrinsic and intrinsic regulation of hematopoiesis and in bone development.